APEN Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 bal. 2023 @ 23:00):

Stats
Šios dienos apimtis	1.64M
Vidutinė apimtis	1.33M
Rinkos kapitalizacija	579.72M
EPS	$0 ( 2024-03-28 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-9.43
ATR14	$0.0390 (0.39%)

Insider Trading

Date	Person	Action	Amount	type
2023-04-04	Mcgaughy R Kent Jr	Sell	400 675	Common Stock
2023-04-04	Mcgaughy R Kent Jr	Sell	38 667	Stock Option (Right to Buy)
2023-04-04	Cpmg Inc	Sell	400 675	Common Stock
2023-04-04	Barr John R	Sell	44 082	Common Stock
2023-04-04	Barr John R	Sell	5 271	Non-Qualified Stock Option (right to buy)

INSIDER POWER
-16.45
Last 98 transactions
Buy: 5 638 377 \| Sell: 4 907 735

Tūris Koreliacija

Ilgas: 0.13 (neutral)

Trumpas: 0.00 (neutral)

Signal:(66.037) Neutral

Apollo Endosurgery Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
NETE	0.955
MDGL	0.952
RAVN	0.922
SRAC	0.9
UFPT	0.886
AGYS	0.883
NRIM	0.882
PODD	0.879
TSBK	0.879
AMRB	0.875

10 Labiausiai neigiamai susiję koreliacijos
BVXV	-0.948
SNPX	-0.938
SVAC	-0.935
FREQ	-0.934
PAIC	-0.933
SVOK	-0.928
TSP	-0.923
ALTM	-0.922
ZI	-0.919
SGRP	-0.917

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Apollo Endosurgery Inc Koreliacija - Valiuta/Žaliavos

0.33
( neutral )

0.47
( neutral )

-0.30
( neutral )

0.41
( neutral )

-0.29
( neutral )

Apollo Endosurgery Inc Finansinės ataskaitos

Annual	2022
Pajamos:	$76.86M
Bruto pelnas:	$42.43M (55.20 %)
EPS:	$-0.980

FY	2022
Pajamos:	$76.86M
Bruto pelnas:	$42.43M (55.20 %)
EPS:	$-0.980

FY	2021
Pajamos:	$62.99M
Bruto pelnas:	$34.96M (55.50 %)
EPS:	$-0.820

FY	2020
Pajamos:	$42.05M
Bruto pelnas:	$22.24M (52.90 %)
EPS:	$-0.990

Financial Reports:

No articles found.

Apollo Endosurgery Inc

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.